Home/Recalls/FDA-D-0432-2026
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a ...

Published: April 15, 2026Recall ID: D-0432-2026Category: drugsCountry: US

Reason for Recall / Hazard

Lack of Assurance of Sterility

Product Description & Identification

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85.

Additional Source Details

FieldValue
CityLake Zurich
StateIL
Openfda › Unii451W47IQ8X
Openfda › RouteINTRAVENOUS
Openfda › Rxcui › 11807634
Openfda › Rxcui › 21807639
Openfda › Spl id904e72e0-2558-4548-8ddd-8c6877c23b98
Openfda › Brand nameSODIUM CHLORIDE
Openfda › Spl set id2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88
Openfda › Package ndc › 165219-432-20
Openfda › Package ndc › 265219-432-85
Openfda › Package ndc › 365219-328-10
Openfda › Package ndc › 465219-328-50
Openfda › Product ndc › 165219-328
Openfda › Product ndc › 265219-432
Openfda › Generic nameSODIUM CHLORIDE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameSODIUM CHLORIDE
Openfda › Manufacturer nameFresenius Kabi USA, LLC
Openfda › Application numberANDA207310
Openfda › Is original packagertrue
Event id98581
Address 13 Corporate Dr
Code infoBatch# 23DU10004, Exp Date: 04/30/2026; Batch# 23HU10006, Exp Date: 06/30/2026.
Postal code60047-8930
Report date20260415
Product typeDrugs
Reason for recallLack of Assurance of Sterility
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260311
Initial firm notificationLetter
Center classification date20260403

Overview

  • Recalling FirmFresenius Kabi USA, LLC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS Nationwide , Alaska, and Puerto Rico.
Official Agency Alert